Académique Documents
Professionnel Documents
Culture Documents
Tetrahedron: Asymmetry
journal homepage: www.elsevier.com/locate/tetasy
Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, H-1521 Budapest, PO Box 91, Hungary
Compound Proling Laboratory, Chemical Works of Gedeon Richter Plc., H-1475 Budapest, PO Box 27, Hungary
c
Research Group for Alkaloid Chemistry of the Hungarian Academy of Sciences, H-1521 Budapest, PO Box 91, Hungary
b
a r t i c l e
i n f o
Article history:
Received 10 January 2012
Accepted 5 April 2012
a b s t r a c t
This paper reports the preparation and testing of three new pyridino-18-crown-6 ether-based chiral stationary phases (S,S)-CSP-12, (S,S)-CSP-17 and (S,S)-CSP-20. Secondary amine (S,S)-7 was rst transformed
to triethoxysilyl derivative (S,S)-11, which contains a urea unit by treating the former with 3-(triethoxysilyl)propyl isocyanate. Next, (S,S)-11 was heated with spherical HPLC quality silica gel in toluene to
obtain (S,S)-CSP-12. In order to acetylate the 3-aminopropylsilyl groups bonded to the silica gel during
immobilization of the triethoxysilyl derivative (S,S)-11, we pumped acetic anhydride and triethylamine
in DMF through the column to give the modied chiral stationary phase (S,S)-CSP-20.
Triate (S,S)-13 was rst transformed to a pyridino-18-crown-6 ether derivative (S,S)-15, which contains a 4-(methoxycarbonyl)phenyl substituent at the 4-position of the pyridine ring by a Suzuki carboncarbon coupling reaction. The hydrolysis of ester (S,S)-15 gave carboxylic acid (S,S)-21. Carboxylic
acid (S,S)-21 was reacted with an excess of thionyl chloride to form the appropriate acyl chloride, which
was treated with 3-(triethoxysilyl)propylamine in the presence of triethylamine in THF to furnish triethoxysilyl derivative (S,S)-16 containing an amide unit. Triethoxysilyl derivative (S,S)-16 was heated with
spherical HPLC quality silica gel in toluene to give the chiral stationary phase (S,S)-CSP-17.
The enantiomer separating ability of chiral stationary phases (S,S)-CSP-12, (S,S)-CSP-17 and (S,S)-CSP20 were tested by using mixtures of enantiomers of 1-(1-naphthyl)ethylamine hydrogen perchlorate
(1-NEA), 1-(2-naphthyl)ethylamine (2-NEA), 1-(4-bromophenyl)ethylamine (Br-PEA) and 1-(4-nitrophenyl)ethylamine hydrogen chloride (NO2-PEA). Chiral stationary phase (S,S)-CSP-17 showed the best
enantiomer separating ability for the mixtures of enantiomers of amine compounds amongst the pyridino-crown ether-based CSPs ever synthesized. The high enantioselectivity is probably due to the strong
pp interaction of the extended p system of the arylsubstituted pyridine unit.
2012 Elsevier Ltd. All rights reserved.
1. Introduction
A study of the enantiomeric recognition of chiral amines and
chiral protonated amines is of great signicance because these
compounds are basic building blocks of biological molecules and
therefore often used as guests.1,2 Cram et al. described the rst synthesis and characterization of a number of chiral crown ethers
capable of enantiomeric recognition towards the above mentioned
amino compounds.3,4 Cram et al. were also the rst to prepare and
utilize chiral stationary phases (CSPs) containing chiral crown
ethers for the resolution of primary amines, amino acids and amino
acid esters. They immobilized optically active bis(1,10 -binaphthyl)-
416
N
R
O *
O
O
O
O
O
ordinary
silica gel
O
O
O
ordinary
silica gel
O
O
O
HPLC quality
silica gel
O
O
O
spherical HPLC
silica gel
O
O
O
spherical HPLC
silica gel
O
O
O
spherical HPLC
silica gel
enantiomers of racemic 1-NEA, 1-(2-naphthyl)ethylamine hydrogen perchlorate (2-NEA), aromatic a-amino acids and aliphatic aamino acids containing different aromatic side-chain protecting
groups very well by applying high pressure.29
In all of the above cases, the enantiopure pyridino-18-crown-6
ether derivatives were attached to silica gel20,21,2629 through an
oxygen atom at the 4-position of the pyridine ring. Our aim was
to work out a suitable synthetic route to such new pyridino-18crown-6 ether derivatives where the linking units at the 4-position
of the pyridine ring are attached through a nitrogen or a carbon
atom.
Herein we report a new route for the synthesis of the reported
enantiopure dimethyl30 (S,S)-5 (Scheme 1) and diisobutyl31 (S,S)-6
(Scheme 1) substituted pyridino-18-crown-6 ethers containing a
chlorine atom at the 4-position of the pyridine ring and also their
transformation into new enantiopure dimethyl- and diisobutylsubstituted pyridino-18-crown-6 ethers containing a butylamino
(S,S)-7 and (S,S)-8 (Scheme 2) or a benzylamino (S,S)-9 and (S,S)10, (Scheme 2) group at the 4-position of the pyridine ring. One
of these secondary amines (S,S)-7 was reacted with 3-(triethoxysilyl)propyl isocyanate to form a triethoxysilyl derivative (S,S)-11
(Scheme 3) containing a urea unit. The latter was immobilized by
417
Cl
N
H
R
A: (COCl)2, DCM
B: (COCl)2, CHCl3
C: SOCl2, DCM
D: SOCl2, CHCl3
O
(S,S)-5: R=Me (A:48%,B:10%,
C:74%,D:67%)
(S,S)-6: R=iBu (D:33%)
(S,S)-18: R=Me
(S,S)-19: R=iBu
covalent bonds on spherical HPLC quality silica gel and this new
CSP (S,S)-CSP-12 (Fig. 1) was used for enantiomeric separation of
NHR'
N
(S,S)-5 or
(S,S)-6
R'-NH2
heating in
a sealed tube
O
(S,S)-7: R=Me, R'=Bu (98%)
(S,S)-8: R= iBu, R'=Bu (98%)
(S,S)-9: R=Me, R'=Bn (88%)
(S,S)-10: R= iBu, R'=Bn (69%)
Scheme 2. Preparation of pyridino-crown ethers containing a secondary amine
moiety (S,S)-7(S,S)-10.
O
OEt
Si OEt
Bu
N
OEt
OCN
Si OEt
OEt
N
H
OEt
N
Me
Me
(S,S)-7
heating in
a sealed tube
O
O
(S,S)-11 (36%)
spherical HPLC
silica gel
(S,S)-11
(S,S)-CSP-12
toluene
heat
Ac2O, TEA
(S,S)-CSP-20
DMF, 40 C
Scheme 3. Preparation and modication of the new chiral stationary phase (S,S)-CSP-12.
418
Me
OTf
N
H
Me
Me
Tf2O, TEA
DCM
r. t.
(S,S)-18
(S,S)-13 (98%)
Me
COOH
N
NaI, CH3CN
Me
Me
(S,S)-13
HCl
r. t.
1)TMAH/H2O, MeOH
Me
Me
(S,S)-15
2) HOAc, rt
(S,S)-14 (57%)
O
O
(S,S)-21 (96%)
tached to spherical HPLC quality silica gel and the new CSP (S,S)CSP-17 (Fig. 1) was used for enantiomeric separation of the mixtures of enantiomers of protonated primary amine compounds
containing an aromatic moiety.
We hoped that the CSPs prepared from the above mentioned
precursors will be more stable than their earlier analogues, and
their discriminating power for the enantiomers of protonated primary amines and amino acid derivatives would be greater. The
pyridine ring substituted with an aromatic linking unit provides
increased pp interactions with aromatic groups of the guest molecules, and by this is expected to increase the degree of enantiomeric recognition.
COOMe
COOMe
B(OH)2
(S,S)-13 or
(S,S)-14
Pd(PPh3)4
K3PO4, KBr
dioxane
85 C
Me
Me
O
(S,S)-15 (68% from (S,S)-13
92% from (S,S)-14)
Scheme 6. Preparation of pyridino-crown ether (S,S)-15 containing a 4-(methoxycarbonyl)phenyl group at the 4-position of the pyridine ring.
419
CONH(CH2)3Si(OEt)3
N
1) SOCl2, 40 C
Me
Me
(S,S)-21
2) H2N(CH 2)3Si(OEt)3
TEA, THF
r. t.
O
O
(S,S)-16 (55%)
spherical HPLC
silica gel
(S,S)-16
toluene
heat
(S,S)-CSP-17
NH3 +ClO4 -
1-(1-naphthyl)ethylamine
hydrogen perchlorate
1-NEA
NH2
Br
1-(4-bromophenyl)ethylamine
Br-PEA
NH 2
1-(2-naphthyl)ethylamine
2-NEA
NH 3+Cl-
NO2
1-(4-nitrophenyl)ethyamine
hydrogen chloride
NO2 -PEA
420
Table 1
Chromatographic data for the separation of mixtures of protonated primary aralkylamine enantiomers on (S,S)-CSP-12
Analytes
t (S) [min]
t (R) [min]
1-NEA
Br-PEA
NO2-PEA
4.61
3.61
2.70
6.22
4.23
2.91
RS
1.67
1.44
1.40
1.67
0.85
0.61
Isocratic conditions: 0.05% HCOOH and 0.2% TEA in a 7:3 mixture of CH3CN/MeOH
(ow rate: 1.0 mL/min).
Table 2
Chromatographic data for the separation of mixtures of protonated primary aralkylamine enantiomers on (S,S)-CSP-20
Analytes
t (S) (min)
t (R) (min)
1-NEA
2-NEA
Br-PEA
NO2-PEA
7.40
8.35
4.97
3.02
11.47
10.92
6.23
3.30
RS
1.78
1.42
1.46
1.35
4.54
1.60
1.00
0.95
Isocratic condition: 0.05% HCOOH and 0.2% TEA in a 7:3 mixture of CH3CN/MeOH
(ow rate: 1.0 mL/min).
Table 3
Chromatographic data for the separation of the mixtures of enantiomers of
protonated primary aralkylamines on (S,S)-CSP-17
Analytes
t (S) (min)
t (R) (min)
1-NEA
2-NEA
Br-PEA
NO2-PEA
16.22
15.79
15.91
16.12
37.79
25.07
23.09
21.86
RS
2.49
1.66
1.51
1.40
9.20
4.53
3.58
3.30
Isocratic conditions: 0.2% HCOOH and 0.1% TEA in a 1:4 mixture of CH3CN/MeOH
(ow rate: 1.0 mL/min).
so electrostatic repulsion between the immobilized protonated 3aminopropylsilyl groups and the analytes does not take place.
Encouraged by the more efcient enantioseparations, we also tried
the chiral stationary phase (S,S)-CSP-20 for the separation of the
mixture of 2-NEA enantiomers. In this case, we also obtained an almost baseline separation (Fig. 4b). By comparing the resolution
data of 2-NEA and 1-NEA, it can be seen that the decrease of the
separation (a) and resolution (Rs) factors (Table 2) is due to the
unfavourable position of the naphthalene ring in the complex.14
The modied chiral stationary phase (S,S)-CSP-20 gives longer
retention times, and better separation and resolution factors for
1-NEA than the reported29 pyridino-crown ether-based (S,S)-CSP4.
421
Figure 4. Chromatograms of enantioseparations of the mixtures of (a) 1-NEA, (b) 2-NEA, (c) Br-PEA, (d) NO2-PEA enantiomers using (S,S)-CSP-20. Isocratic conditions: 0.05%
HCOOH and 0.2% TEA in a 7:3 mixture of CH3CN/MeOH (ow rate: 1.0 mL/min).
422
Figure 5. Chromatograms of enantioseparations of mixtures of (a) 1-NEA, (b) 2-NEA, (c) Br-PEA, (d) NO2-PEA enantiomers using (S,S)-CSP-17. Isocratic condition: 0.2%
HCOOH and 0.1% TEA in a 1:4 mixture of CH3CN/MeOH (ow rate: 1.0 mL/min).
Table 4
Comparison of chromatographic data for the separation of the mixtures of enantiomers of protonated primary aralkylamines on (S,S)-CSP-12, (S,S)-CSP-20 and (S,S)-CSP-17
Chiral stationary phase
Analytes
t (S) (min)
t (R) (min)
(S,S)-CSP-12
(S,S)-CSP-20
(S,S)-CSP-17
(S,S)-CSP-12
(S,S)-CSP-20
(S,S)-CSP-17
(S,S)-CSP-12
(S,S)-CSP-20
(S,S)-CSP-17
(S,S)-CSP-20
(S,S)-CSP-17
1-NEA
1-NEA
1-NEA
Br-PEA
Br-PEA
Br-PEA
NO2-PEA
NO2-PEA
NO2-PEA
2-NEA
2-NEA
4.61
7.40
16.22
3.61
4.97
15.91
2.70
3.02
16.12
8.35
15.79
6.22
11.47
37.79
4.23
6.23
23.09
2.91
3.30
21.86
10.92
25.07
RS
Eluent
1.67
1.78
2.49
1.44
1.46
1.51
1.40
1.35
1.40
1.42
1.66
1.67
4.54
9.20
0.85
1.00
3.58
0.61
0.95
3.30
1.60
4.53
A
A
B
A
A
B
A
A
B
A
B
A: Isocratic conditions: 0.05% HCOOH and 0.2% TEA in a 7:3 mixture of CH3CN/MeOH (ow rate: 1.0 mL/min).
B: Isocratic conditions: 0.2% HCOOH and 0.1% TEA in a 1:4 mixture of CH3CN/MeOH (ow rate: 1.0 mL/min).
recorded in CDCl3 either on a Bruker DRX-500 Avance spectrometer (at 500 MHz for 1H and at 125 MHz for 13C spectra) or on a
Bruker 300 Avance spectrometer (at 300 MHz for 1H and at
75 MHz for 13C spectra) and it is indicated in each individual
case. Mass spectra were recorded on an Agilent-1200 Quadrupole LC/MS instrument using ESI method. Elemental analyses
were performed in the Microanalytical Laboratory of the Department of Organic Chemistry, Institute for Chemistry, L. Etvs
Lornd University, Budapest, Hungary. Melting points were taken
on a Boetius micro-melting point apparatus and are uncorrected.
For the microwave irradiation, we used a CEM Discover (maxi-
423
established methods.42 Evaporations were carried out under reduced pressure unless otherwise stated.
yellow oil. Macrocycle (S,S)-6 obtained in this way had the same
spectroscopic data as that reported in the literature.31
4.2.3. General procedure for the preparation of the pyridinocrown ethers containing a secondary amino group (S,S)-7(S,S)10 (see Scheme 2)
Chloropyridino-crown ether (S,S)-5 or (S,S)-6 (0.226 mmol) and
primary amine (0.677 mmol) were heated in a sealed tube at
160 C for 8 days. The excess of primary amine was evaporated,
the residue was taken up in DCM (5 mL), and the solution was
washed with 12.5% aqueous TMAH (5 mL). The aqueous layer
was extracted with DCM (3 5 mL). The combined organic phase
was dried over MgSO4, ltered and the solvent was evaporated.
The crude product was puried as described below for each compound to give the optically active pyridino-crown ethers (S,S)-7
(S,S)-10.
4.2.3.1. (4S,14S)-(+)-N-Butyl-4,14-dimethyl-3,6,9,12,15-pentaoxa-21-azabicyclo[15.3.1]heneicosa-1(21)-17,19-triene-19-amine
(S,S)-7 (see Scheme 2).
Crown ether (S,S)-7 was prepared as
described above in the General procedure starting from dimethyl-substituted chloropyridino-crown ether (S,S)-5 (513.5 mg,
1.42 mmol) and butylamine (0.42 mL, 313 mg, 4.28 mmol). The
crude product was puried by column chromatography on neutral
aluminium oxide using EtOHtoluene (1:20) mixture as an eluent
to yield (S,S)-7 (554 mg, 98%) as a pale yellow oil. RF: 0.46 (alumina
TLC, EtOHtoluene = 1:10). a25
D 15:3 (c 0.91, DCM); IR (lm)
mmax 3244, 2957, 2929, 2863, 1606, 1523, 1258, 1351, 1102, 982,
921, 842 cm1; 1H NMR (500 MHz, CDCl3) d (ppm) 0.95 (t, 3H,
J = 7.5 Hz), 1.17 (d, 6H), 1.381.45 (m, 2H), 1.571.63 (m, 2H),
3.15 (q, 2H, J = 7 Hz), 3.433.65 (m, 13H), 3.783.84 (m, 2H), the
diastereotopic benzylic type protons give an AB quartet dA: 4.57
and dB: 4.65 (JAB = 13 Hz, 4H), 6.45 (s, 2H); 13C NMR (125 MHz,
CDCl3) d (ppm) 13.97, 17.16, 20.33, 31.36, 42.60, 70.65, 70.86,
71.95, 73.68, 75.76, 104.65, 155.11, 157.97; MS: 396.3 (M+1)+;
Anal. Calcd for C21H36N2O5: C, 63.61; H, 9.15; N, 7.06. Found: C,
63.31; H, 9.22; N, 7.03.
4.2.3.2. (4S,14S)-()-N-Butyl-4,14-diisobutyl-3,6,9,12,15-pentaoxa-21-azabicyclo[15.3.1]heneicosa-1(21)-17,19-triene-19amine (S,S)-8 (see Scheme 2).
Crown ether (S,S)-8 was prepared as described above in the General procedure starting from
diisobutyl-substituted chloropyridino-crown ether (S,S)-6 (34 mg,
0.0763 mmol) and butylamine (23 lL, 16.7 mg, 0.229 mmol). The
crude product was puried by column chromatography on neutral
aluminium oxide using EtOHtoluene (1:20) mixture as an eluent
to yield (S,S)-8 (36.1 mg, 98%) as a pale yellow oil. RF: 0.62 (alumina
TLC, EtOHtoluene = 1:10). a25
D 11:3 (c 0.73, DCM); IR (lm)
mmax 3246, 2953, 2926, 2868, 1674, 1606, 1524, 1466, 1365,
1351, 1260, 1189, 1091, 1040, 982, 950, 874, 842, 799, 668, 659,
597, 529, 440 cm1; 1H NMR (500 MHz, CDCl3) d (ppm) 0.89
0.94 (m, 15H), 1.191.26 (m, 2H), 1.391.66 (m, 6H), 1.721.81
(m, 2H), 3.153.22 (m, 2H), 3.513.69 (m, 15H), 4.604.70 (m,
4H), 6.47 (s, 2H); 13C NMR (125 MHz, CDCl3) d (ppm) 13.98,
20.39, 22.71, 23.45, 24.95, 29.90, 31.26, 41.06, 42.77, 70.66,
71.00, 74.68, 103.56, 154.42, 158.68; MS 480.4 (M+1)+; Anal. Calcd
for C27H48N2O5: C, 67.46; H, 10.07; N, 5.83. Found: C, 67.18; H,
10.36; N, 5.67.
4.2.3.3. (4S,14S)-(+)-N-Benzyl-4,14-dimethyl-3,6,9,12,15-pentaoxa-21-azabicyclo[15.3.1]heneicosa-1(21)-17,19-triene-19amine (S,S)-9 (see Scheme 2).
Crown ether (S,S)-9 was prepared as described above in the General procedure starting from
dimethyl-substituted chloropyridino-crown ether (S,S)-5 (50 mg,
0.139 mmol) and benzylamine (47 lL, 44.7 mg, 0.417 mmol). The
crude product was puried by column chromatography on neutral
424
(81.7 lL, 59.3 mg, 0.59 mmol), after which Tf2O (98.7 lL, 165.3 mg,
0.59 mmol) was added dropwise via a syringe and a needle over 5
minutes. After warming the reaction mixture to room temperature,
it was stirred until TLC analysis (Al2O3 TLC; EtOHtoluene 1:40)
showed the total consumption of the starting material
(Rf(S,S)-18 = 0.07) and only one main spot (Rf(S,S)-13 = 0.50) for the
product (0.5 h). The reaction mixture was poured into ice-water
(10 mL) and the pH of the mixture was adjusted to 10 with 25%
aqueous tetramethyl ammonium hydroxide (TMAH). The mixture
was washed into a separating funnel with DCM (10 mL). The
resulting mixture was shaken well and separated. The aqueous
phase was shaken with DCM (3 10 mL). The combined organic
phase was dried over anhydrous MgSO4, ltered and the solvent
was evaporated. The dark purple coloured residue was puried
by column chromatography on silica gel using acetonetoluene
(1:1) mixture as an eluent to furnish triate (S,S)-13 (135.9 mg,
98%) as a pale brown oil. RF: 0.50 (alumina TLC, EtOHtoluene = 1:40). a25
D 11:8 (c 2.46, DCM); IR (lm) mmax 2970,
2870, 1596, 1579, 1424, 1375, 1351, 1335, 1295, 1242, 1211,
1136, 1114, 1031, 1014, 955, 924, 874, 817, 765, 669, 639, 604,
572, 516 cm1; 1H NMR (500 MHz, CDCl3) d (ppm) 1.19 (d, 6H,
J = 6 Hz, CH3 groups attached to the macro ring), 3.463.61 (m,
12H, OCH2), 3.813.87 (m, 2H, OCHCH3), 4.89 (s, 4H, benzylic type
CH2O), 7.24 (s, 2H, Pyr-H); 13C NMR (75 MHz, CDCl3) d (ppm) 17.18,
70.82, 71.11, 71.39, 74.53, 76.49, 112.29, 157.41, 162.93; MS: 474.4
(M+1)+; Anal. Calcd for C18H26F3NO8S: C, 45.66; H, 5.54; F: 12.04;
N, 2.96; S, 6.77. Found: C, 45.27; H, 5.72; F: 12.09; N, 2.81; S, 6.54.
4.3.2. (4S,14S)-(+)-19-Iodo-4,14-dimethyl-3,6,9,12,15-pentaoxa21-azabicyclo[15.3.1]heneicosa-1(21),17,19-triene (S,S)-14 (see
Scheme 5)
To a solution of triate (S,S)-13 (100 mg, 0.211 mmol) in CH3CN
(5 mL) was rst added NaI (158.3 mg, 1.056 mmol) followed by
30% aqueous HCl (30.8 mg, 0.253 mmol) and the resulting mixture
was stirred at room temperature until TLC analysis (Al2O3 TLC;
EtOHtoluene 1:40) showed the total consumption of the starting
material (Rf(S,S)-13 = 0.50) and only one main spot (Rf(S,S)-14 = 0.37)
for the product (5 h). The volatile components were evaporated,
the residue was diluted with water (5 mL), and the pH of the mixture was adjusted to 10 with 1 M NaOH. The mixture was washed
into a separating funnel with toluene (5 mL). The resulting mixture
was shaken well and separated. The aqueous phase was shaken
with toluene (3 5 mL). The combined organic phase was washed
with 5% aqueous Na2S2O3 (20 mL), 1 M NaOH (20 mL) and water
(3 20 mL). The organic phase was dried over anhydrous MgSO4,
ltered and the solvent was evaporated to give (S,S)-14 (95.2 mg,
57%) as a pale brown oil. RF: 0.37 (alumina TLC, EtOHtoluene = 1:40). a25
D 13:4 (c 2.09, DCM); IR (lm) mmax 2966,
2861, 1559, 1450, 1404, 1370, 1349, 1331, 1260, 1111, 924, 858,
799, 747, 660, 633, 599, 578, 550, 535, 514, 488 cm1; 1H NMR
(500 MHz, CDCl3) d (ppm) 1.17 (d, 6H, J = 6 Hz, CH3 groups attached
to the macroring), 3.443.63 (m, 12H, OCH2), 3.773.83 (m, 2H,
OCHCH3), 4.76 (s, 4H, benzylic type CH2O), 7.63 (s, 2H, Pyr-H);
13
C NMR (75 MHz, CDCl3) d (ppm) 17.20, 70.85, 71.07, 71.34,
74.23, 76.34, 106.51, 129.44, 159.73; MS: 452.2 (M+1)+; Anal. Calcd
for C17H26INO5: C, 45.24; H, 5.81; I: 28.12; N, 3.10. Found: C, 45.12;
H, 5.92; I: 28.07; N, 3.09.
4.3.3. Methyl 4-[(4S,14S)-()-4,14-dimethyl-3,6,9,12,15-pentaoxa-21-azabicyclo[15.3.1]heneicosa-1(21),17,19-triene-19-yl]benzoate (S,S)-15 (see Scheme 6)
4.3.3.1. Starting from triate (S,S)-13 (see Scheme 6).
A mixture of pyridino-crown ether triate (S,S)-13 (101.5 mg, 0.21
mmol), 4-(methoxycarbonyl)phenylboronic acid (42.5 mg, 0.236
mmol), Pd(PPh3)4 (6.2 mg, 0.0054 mmol), powdered K3PO4
(68.3 mg, 0.32 mmol) and KBr (28.1 mg, 0.236 mmol) in dioxane
425
426
427